Open ValWood opened 7 months ago
I need to check where this modification occurs (I read that it occurs later in cytoplasm, so this does not seem to be part of the co-transcriptional processing pathway), it might be better to keep it separate:
if the conversion of 7-methylguanosine (m7G) cap to the 2,2,7-trimethylguanosine (TMG) cap happens in the nucleus we can stick with the original plan
Please provide as much information as you can:
currently this represents a single step, the conversion of a "7-(mono)methylguanosine (m(7)G) cap" to a 2,2,7-trimethylguanosine cap structure.
The proposal is to make 2 new terms snoRNA 2,2,7-trimethylguanosine (TMG) cap formation snRNA 2,2,7-trimethylguanosine (TMG) cap formation
to replace this term.
Annotations should be made to the MF term and snoRNA 2,2,7-trimethylguanosine (TMG) cap formation
but the new terms, instead of representing only a single step in the pathway can be used to annotate all of the steps in sn/sno capping (including the 3 steps shared with mRNA capping) so that the entire pathway can be reconstituted unambiguously.
Reason for deprecation Put an x in the appropriate box:
"Replace by" term (ID and label) If all annotations can safely be moved to that term
Action https://github.com/geneontology/go-ontology/issues/26940 first
"Consider" term(s) (ID and label) Suggestions for reannotation
Are there annotations to this term?
How many EXP:
Are there mappings and cross references to this term? (InterPro, Keywords; check QuickGO cross-references section)
Is this term in a subset? (check the AmiGO page for that term)
Any other information
Checklist for ontology editor
Check term usage and metadata in Protégé
Check annotations
Notification